MyFinsight
Home
Blog
About
Inventory
$904,273K
(-9.03%↓ Y/Y)
Cash and cash
equivalents
$571,148K
(11.86%↑ Y/Y)
Accounts receivable, net
$376,824K
(-28.54%↓ Y/Y)
Short-term investments
$217,341K
(-24.94%↓ Y/Y)
Other current assets
$105,784K
(-17.09%↓ Y/Y)
Manufacturing-related deposits and
prepaids
$48,454K
(-76.70%↓ Y/Y)
Total current assets
$2,223,824K
(-16.30%↓ Y/Y)
Property and equipment,
net
$325,991K
(-12.33%↓ Y/Y)
Non-current inventory
$226,333K
(16.27%↑ Y/Y)
Other non-current
assets
$146,145K
(75.79%↑ Y/Y)
Non-current investments
$145,372K
(320.10%↑ Y/Y)
Right of use assets
$120,847K
(-15.52%↓ Y/Y)
Total assets
$3,188,512K
(-13.35%↓ Y/Y)
Total liabilities and
stockholders equity
$3,188,512K
(-13.35%↓ Y/Y)
Total liabilities
$1,660,714K
(-28.49%↓ Y/Y)
Total stockholders
equity
$1,527,798K
(12.55%↑ Y/Y)
Accumulated deficit
-$4,550,915K
(-2.00%↓ Y/Y)
Treasury stock, at cost,
655,642 and 650,876...
$25,263K
(0.00%↑ Y/Y)
Accumulated other
comprehensive income (loss),...
-$565K
(-1007.84%↓ Y/Y)
Long-term debt
$847,623K
(-25.61%↓ Y/Y)
Total current
liabilities
$502,908K
(-45.33%↓ Y/Y)
Lease liabilities,
net of current...
$198,226K
(-7.55%↓ Y/Y)
Deferred revenue, net of
current portion
$110,132K
Other non-current
liabilities
$1,825K
(51.58%↑ Y/Y)
Additional paid-in capital
$6,104,530K
(4.45%↑ Y/Y)
Common stock, 0.0001
par value,...
$11K
(10.00%↑ Y/Y)
Accrued expenses
$325,232K
(-13.82%↓ Y/Y)
Deferred revenue,
current portion
$110,132K
(-72.15%↓ Y/Y)
Accounts payable
$50,982K
(-62.71%↓ Y/Y)
Other current
liabilities
$16,562K
(59.01%↑ Y/Y)
Back
Back
Balance Sheet
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)
logo (1) copy-svg
source: myfinsight.com
Sarepta Therapeutics, Inc. (SRPT)